SCHEMBL8262002

SCHEMBL8262002

Nc1cccc(CNc2ccc(Cl)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.50
MEF2D Q14814 1/20 0.50
CYP19A1 P11511 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
RAB9A P51151 1/20 0.46
BPTF Q12830 1/20 0.46
DHFR P00374 1/20 0.45
CNR2 P34972 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.43
MAP3K8 P41279 1/20 0.43
HDAC1 Q13547 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2993170 0.87 CYP19A1 (0.55) CYP19A1MEN1KMT2ARAB9ABPTF
SCHEMBL11510712 0.84 HDAC4 (0.54) HDAC4MEF2DCYP19A1MEN1KMT2A
SCHEMBL17266296 0.84 MAOA (0.57) HDAC4MEF2DMEN1KMT2ARAB9A
SCHEMBL11248387 0.82 MAOA (0.48) CYP19A1MEN1KMT2ABPTFALDH1A1
Hydrochloric Acid SCHEMBL11247111 0.80 MAOA (0.50) CYP19A1MEN1KMT2ABPTFMAPT
Hydrochloric Acid SCHEMBL11247122 0.80 MAOA (0.50) CYP19A1MEN1KMT2ABPTFMAPT
SCHEMBL5153716 0.80 MAOA (0.49) CYP19A1MEN1KMT2ARAB9AALDH1A1
SCHEMBL6755669 0.79 ADRA2B (0.54) CYP19A1BPTFMAOAMAOB
SCHEMBL5846731 0.79 MAOA (0.43) CYP19A1BPTFMAOAMAOB
SCHEMBL13812986 0.79 MAPT (0.59) MEN1KMT2ANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006066896-A2 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN NOVARTIS AG (CH) 2006-06-29 WO disclosed